A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä
The FLUKA Monte Carlo code coupled with an OER model for biologically weighted dose calculations in proton therapy of hypoxic tumors
Tekijät: Tordis Johnsen Dahle, Espen Rusten, Camilla Hanquist Stokkevåg, Antti Silvoniemi, Andrea Mairan, Lars Fredrik Fjæra, Eivind Rørvik, Helge Henjum, Pauliina Wright, Camilla Grindeland Boer, Sarita Forsback, Heikki Minn, Eirik Malinen, Kristian Smeland Ytre-Hauge
Kustantaja: ELSEVIER SCI LTD
Julkaisuvuosi: 2020
Journal: Physica Medica
Tietokannassa oleva lehden nimi: PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS
Lehden akronyymi: PHYS MEDICA
Vuosikerta: 76
Aloitussivu: 166
Lopetussivu: 172
Sivujen määrä: 7
ISSN: 1120-1797
eISSN: 1724-191X
DOI: https://doi.org/10.1016/j.ejmp.2020.07.003
Rinnakkaistallenteen osoite: https://research.utu.fi/converis/portal/detail/Publication/50689163
Introduction: The increased radioresistance of hypoxic cells compared to well-oxygenated cells is quantified by the oxygen enhancement ratio (OER). In this study we created a FLUKA Monte Carlo based tool for inclusion of both OER and relative biological effectiveness (RBE) in biologically weighted dose (ROWD) calculations in proton therapy and applied this to explore the impact of hypoxia.
Methods: The RBE-weighted dose was adapted for hypoxia by making RBE model parameters dependent on the OER, in addition to the linear energy transfer (LET). The OER depends on the partial oxygen pressure (pO(2)) and LET. To demonstrate model performance, calculations were done with spread-out Bragg peaks (SOBP) in water phantoms with pO(2) ranging from strongly hypoxic to normoxic (0.01-30 mmHg) and with a head and neck cancer proton plan optimized with an RBE of 1.1 and pO(2) estimated voxel-by-voxel using [F-18]-EF5 PET. An RBE of 1.1 and the Rorvik RBE model were used for the ROWD calculations.
Results: The SOBP in water had decreasing ROWD with decreasing pO(2). In the plans accounting for oxygenation, the median target doses were approximately a factor 1.1 lower than the corresponding plans which did not consider the OER. Hypoxia adapted target ROWDs were considerably more heterogeneous than the RBE1.1-weighted doses.
Conclusion: We realized a Monte Carlo based tool for calculating the ROWD. Read-in of patient pO(2) and estimation of ROWD with flexibility in choice of RBE model was achieved, giving a tool that may be useful in future clinical applications of hypoxia-guided particle therapy.
Ladattava julkaisu This is an electronic reprint of the original article. |  |
